OPRX (OptimizeRx) Forward P/S Multiple

Public company logo of OptimizeRx Inc. (OPRX)

The scaling of the marketing platform and long-term agreements with pharmaceutical behemoths create a sustainable profit stream for OptimizeRx Corporation (OPRX). The forward P/S indicator visualizes this trend, with the metric holding around 0.50. The business model relies on B2B advertising within electronic health records, while the high margins of digital services guarantee excess liquidity with low development costs.

OPRX OptimizeRx Corp: Forward Price to Sales in the range 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for OptimizeRx Inc. (OPRX)

- stock price and consensus target price:
Analysis of all company metrics:OPRX (OptimizeRx)
Manufactured products of OptimizeRx Inc.

To select high-quality assets, it is essential for an investor to compare a company's market value with its projected revenue stream to determine the degree of business overvaluation. This calculation, reflecting the ratio of market capitalization to expected earnings, allows for an assessment of the effectiveness of OptimizeRx Corporation (OPRX) digitalization of marketing at points of care, where the forward P/S ratio trend serves as an indicator of the sustainability of its cloud product expansion.

Competitor analysis

Veeva - Forward Price-to-Revenue Multiple|DOCS (Doximity Inc) - Future Price to Revenue|HealthEquity Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Waystar Corp|CorVel Corporation (CRVL) - Price-to-Projected Revenue Ratio|priviahealth.com - Forward Price to Sales|Forward Price-to-Revenue Multiple HURN|Market Cap to Projected Revenue CERT (Certara Inc)|Forward Price-to-Revenue Multiple OMCL (Omnicell Corp)|GDRX (GoodRx Gold) - Forward Price to Sales|Forward P/S Multiple SDGR (Schrodinger, Inc.)|PHR - Forward Price-to-Revenue Multiple|OMDA - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Evolent Health Inc|HealthStream Corp (HSTM) - Price-to-Projected Revenue Ratio|Definitive Corp - Forward Price to Sales|Price-to-Projected Revenue Ratio Consensus Cloud Solutions|agilonhealth.com - Future Price to Revenue|Price-to-Projected Revenue Ratio Absci Corporation (ABSI)|SY - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio National Research Corporation NRC|Forward Price to Sales SPOK|TruBridge, Inc. - Forward P/S Multiple|SLP - Forward P/S Multiple|SOPH (sophiagenetics.com) - Forward Price-to-Revenue Multiple|HCAT: Price to Expected Revenue Ratio|CCLD (CareCloud Inc.) - Forward P/S Multiple|Research Solutions Inc. (RSSS) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio DLH Holdings Corp. (DLHC)|ONMD - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Scienture SCNX|HCTI: Market Cap to Projected Revenue|ISPC - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Bullfrog AI Holdings|SCWorx Corp. (WORX) - Price-to-Projected Revenue Ratio|Future Price to Revenue MSPR (msprecovery.com)|Price-to-Projected Revenue Ratio iCoreConnect, Inc.|MEDS: Forward Price to Sales|Forward Price-to-Revenue Multiple ORGS (Orgenesis Corp)|r1rcm.com - Market Cap to Projected Revenue|Forward P/S Multiple SHCR (Sharecare, Inc.)|Market Cap to Expected Sales Ratio streamlinehealth.net (STRM)|SYRA: Forward Price-to-Revenue Multiple|Apollo Medical Holdings - Price to Expected Revenue Ratio|MODN (Model N Corp) - Forward Price-to-Revenue Multiple|NextGen Healthcare Corp - Forward Price to Sales